Pancreatic Cancer Research

ResearcherMedical University of SilesiaActive in the last 2 years

Łukasz Liszka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6912-224X; OpenAlex author ID A5069731083. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Complete Pathological Response to Neoadjuvant Treatment in Pancreatic Ductal Adenocarcinoma-Can We Achieve a Long-Term Survival? A Narrative Review. Co-author DOI 10.3390/life15121833↗
  2. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma. First author DOI 10.1002/1878-0261.13576↗
  3. Precursor lesions of early onset pancreatic cancer. Co-author DOI 10.1007/s00428-011-1056-3↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sławomir Mrowiec · 2 shared papers, 2011–2025 · strength 0.36
  2. Magdalena Gajda · 1 shared paper, 2025 · strength 0.33
  3. Ewa Grudzińska · 1 shared paper, 2025 · strength 0.33
  4. Chara Ntala · 1 shared paper, 2024 · strength 0.20
  5. Silvana Debernardi · 1 shared paper, 2024 · strength 0.20
  6. Iréne Esposito · 1 shared paper, 2024 · strength 0.20
  7. Tatjana Crnogorac‐Jurcevic · 1 shared paper, 2024 · strength 0.20
  8. Paweł Lampe · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.